Ningbo Menovo Pharmaceutical Co., Ltd.

¥21.65As of Sun 8 Nov 2026, 12:00 UTC
SSE:603538Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 4.07%
Div yield 0.51%
ROE 4.07%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM 61.91
TSR TTM 27.70%
Mkt cap ¥7.359B
ROIC 3.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
29.63%
(73.90%)
Hold 4|3|9|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.34
0.33
0.37
0.37
8.14%
(0.44%)
7.70%
14.73%
Revenue¥M
431.1
422.5
443.2
430.4
3.57%
2.45%
10.67%
3.53%
Peers (US$1.103B)
Cap (US$)
PE
1.112B
54.61x
1.094B
—
1.085B
14.18x
Capital
TTM
5Y
10Y
Leveragex
0.715
0.282
0.229
EBIT/Intx
2.794
0.497
0.484
Own earn%
(45.79)
(72.39)
(79.62)
Sh yield%
22.47
24.51
24.59
Owners
Insiders/Inst%
0.12
24.70
Short interest%
4.49
SBC / revenue%
2.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
12–17
$1 testx
0.6
Incr. ROIC%
4